Research Analysts’ Recent Ratings Updates for BrightSpring Health Services (BTSG)

BrightSpring Health Services (NASDAQ: BTSG) has recently received a number of price target changes and ratings updates:

• 5/4/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $60.00 price target on the stock.
• 5/4/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by TD Cowen.
• 5/4/2026 – BrightSpring Health Services had its price target raised by Stephens from $53.00 to $64.00. They now have an “overweight” rating on the stock.
• 5/4/2026 – BrightSpring Health Services had its price target raised by KeyCorp from $55.00 to $60.00. They now have an “overweight” rating on the stock.
• 5/4/2026 – BrightSpring Health Services had its “overweight” rating reaffirmed by Wells Fargo & Company. They now have a $61.00 price target on the stock.
• 5/4/2026 – BrightSpring Health Services had its price target raised by BTIG Research from $55.00 to $65.00. They now have a “buy” rating on the stock.
• 5/1/2026 – BrightSpring Health Services had its price target raised by BMO Capital Markets from $52.00 to $60.00. They now have an “outperform” rating on the stock.
• 3/19/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by BTIG Research. They now have a $55.00 price target on the stock.
• 3/18/2026 – BrightSpring Health Services had its “outperform” rating reaffirmed by Leerink Partners. They now have a $49.00 price target on the stock.
• 3/18/2026 – BrightSpring Health Services had its price target raised by UBS Group AG from $53.00 to $55.00. They now have a “buy” rating on the stock.
• 3/18/2026 – BrightSpring Health Services had its price target raised by Mizuho from $50.00 to $52.00. They now have an “outperform” rating on the stock.

Insider Buying and Selling

In related news, insider Lisa A. Nalley sold 30,000 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $1,234,500.00. Following the sale, the insider directly owned 110,594 shares of the company’s stock, valued at approximately $4,550,943.10. This represents a 21.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Jennifer A. Phipps sold 35,000 shares of the company’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total transaction of $1,440,250.00. Following the completion of the transaction, the chief financial officer owned 196,840 shares of the company’s stock, valued at approximately $8,099,966. This trade represents a 15.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 285,000 shares of company stock valued at $11,727,750. Corporate insiders own 2.80% of the company’s stock.

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.